nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ABCC1—Dactinomycin—ocular cancer	0.338	0.35	CbGbCtD
Conjugated Estrogens—ABCG2—Dactinomycin—ocular cancer	0.226	0.234	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—ocular cancer	0.168	0.174	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—ocular cancer	0.152	0.157	CbGbCtD
Conjugated Estrogens—ABCB1—Dactinomycin—ocular cancer	0.0815	0.0844	CbGbCtD
Conjugated Estrogens—Venous thrombosis—Carboplatin—ocular cancer	0.00129	0.155	CcSEcCtD
Conjugated Estrogens—Fluid overload—Carboplatin—ocular cancer	0.00112	0.134	CcSEcCtD
Conjugated Estrogens—Extravasation—Carboplatin—ocular cancer	0.000799	0.0958	CcSEcCtD
Conjugated Estrogens—Phlebitis—Carboplatin—ocular cancer	0.000588	0.0704	CcSEcCtD
Conjugated Estrogens—Coagulopathy—Dactinomycin—ocular cancer	0.000333	0.0399	CcSEcCtD
Conjugated Estrogens—Necrosis—Dactinomycin—ocular cancer	0.00033	0.0395	CcSEcCtD
Conjugated Estrogens—Extravasation—Dactinomycin—ocular cancer	0.000297	0.0356	CcSEcCtD
Conjugated Estrogens—Hypocalcaemia—Dactinomycin—ocular cancer	0.000283	0.0339	CcSEcCtD
Conjugated Estrogens—Ulcer—Dactinomycin—ocular cancer	0.000274	0.0328	CcSEcCtD
Conjugated Estrogens—Infection—Carboplatin—ocular cancer	0.000247	0.0296	CcSEcCtD
Conjugated Estrogens—Sepsis—Dactinomycin—ocular cancer	0.000225	0.0269	CcSEcCtD
Conjugated Estrogens—Phlebitis—Dactinomycin—ocular cancer	0.000218	0.0262	CcSEcCtD
Conjugated Estrogens—Pain—Carboplatin—ocular cancer	0.000213	0.0255	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Carboplatin—ocular cancer	0.000197	0.0236	CcSEcCtD
Conjugated Estrogens—Dysphagia—Dactinomycin—ocular cancer	0.000162	0.0195	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Dactinomycin—ocular cancer	0.000129	0.0155	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Dactinomycin—ocular cancer	0.000123	0.0147	CcSEcCtD
Conjugated Estrogens—Alopecia—Dactinomycin—ocular cancer	0.000115	0.0138	CcSEcCtD
Conjugated Estrogens—Erythema—Dactinomycin—ocular cancer	0.000113	0.0136	CcSEcCtD
Conjugated Estrogens—Myalgia—Dactinomycin—ocular cancer	9.64e-05	0.0116	CcSEcCtD
Conjugated Estrogens—Oedema—Dactinomycin—ocular cancer	9.24e-05	0.0111	CcSEcCtD
Conjugated Estrogens—Infection—Dactinomycin—ocular cancer	9.18e-05	0.011	CcSEcCtD
Conjugated Estrogens—Anorexia—Dactinomycin—ocular cancer	8.81e-05	0.0106	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Dactinomycin—ocular cancer	8.42e-05	0.0101	CcSEcCtD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—E2F4—ocular cancer	8.37e-05	0.00323	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—RBL1—ocular cancer	8.2e-05	0.00317	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—E2F5—ocular cancer	8.15e-05	0.00315	CbGpPWpGaD
Conjugated Estrogens—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	8.03e-05	0.0031	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Dactinomycin—ocular cancer	8.03e-05	0.00963	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of Telomerase—CDKN1B—ocular cancer	8.02e-05	0.0031	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—E2F4—ocular cancer	7.99e-05	0.00309	CbGpPWpGaD
Conjugated Estrogens—Fatigue—Dactinomycin—ocular cancer	7.96e-05	0.00955	CcSEcCtD
Conjugated Estrogens—Pain—Dactinomycin—ocular cancer	7.9e-05	0.00947	CcSEcCtD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—EP300—ocular cancer	7.89e-05	0.00305	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—CDKN1B—ocular cancer	7.84e-05	0.00303	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—RPL39—ocular cancer	7.83e-05	0.00303	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—RBL1—ocular cancer	7.83e-05	0.00303	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	7.81e-05	0.00302	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PSPH—ocular cancer	7.74e-05	0.00299	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	7.68e-05	0.00297	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—CCND1—ocular cancer	7.65e-05	0.00296	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	7.63e-05	0.00295	CbGpPWpGaD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—HDAC1—ocular cancer	7.62e-05	0.00294	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal pain—Dactinomycin—ocular cancer	7.55e-05	0.00906	CcSEcCtD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—CCND1—ocular cancer	7.48e-05	0.00289	CbGpPWpGaD
Conjugated Estrogens—ESR1—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	7.39e-05	0.00286	CbGpPWpGaD
Conjugated Estrogens—Body temperature increased—Dactinomycin—ocular cancer	7.3e-05	0.00875	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Dactinomycin—ocular cancer	7.3e-05	0.00875	CcSEcCtD
Conjugated Estrogens—ESR1—LKB1 signaling events—TP53—ocular cancer	7.27e-05	0.00281	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	7.24e-05	0.0028	CbGpPWpGaD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	7.23e-05	0.00279	CbGpPWpGaD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—EP300—ocular cancer	7.19e-05	0.00278	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Platelet degranulation—TGFB1—ocular cancer	7.17e-05	0.00277	CbGpPWpGaD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—MDM2—ocular cancer	7.14e-05	0.00276	CbGpPWpGaD
Conjugated Estrogens—ESR1—Leptin signaling pathway—CCND1—ocular cancer	7.08e-05	0.00273	CbGpPWpGaD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	7.06e-05	0.00273	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—SF3B1—ocular cancer	7.01e-05	0.00271	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	6.96e-05	0.00269	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	6.93e-05	0.00268	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—EP300—ocular cancer	6.88e-05	0.00266	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	6.84e-05	0.00264	CbGpPWpGaD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—CDKN2B—ocular cancer	6.83e-05	0.00264	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Dactinomycin—ocular cancer	6.81e-05	0.00816	CcSEcCtD
Conjugated Estrogens—ESR2—Gene Expression—RBBP4—ocular cancer	6.79e-05	0.00263	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PSPH—ocular cancer	6.74e-05	0.0026	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	6.64e-05	0.00257	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Dactinomycin—ocular cancer	6.63e-05	0.00795	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	6.62e-05	0.00256	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—TFDP1—ocular cancer	6.61e-05	0.00256	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	6.59e-05	0.00255	CbGpPWpGaD
Conjugated Estrogens—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	6.44e-05	0.00249	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	6.44e-05	0.00249	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	6.43e-05	0.00248	CbGpPWpGaD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	6.38e-05	0.00247	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	6.36e-05	0.00246	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Dactinomycin—ocular cancer	6.32e-05	0.00758	CcSEcCtD
Conjugated Estrogens—ESR2—Gene Expression—TFDP1—ocular cancer	6.31e-05	0.00244	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	6.26e-05	0.00242	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—MYC—ocular cancer	6.14e-05	0.00237	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	6.12e-05	0.00237	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—TGFB1—ocular cancer	6.12e-05	0.00237	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	6.11e-05	0.00236	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PSPH—ocular cancer	6.06e-05	0.00234	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—MYC—ocular cancer	6e-05	0.00232	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—TGFB1—ocular cancer	5.98e-05	0.00231	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	5.95e-05	0.0023	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Dactinomycin—ocular cancer	5.87e-05	0.00704	CcSEcCtD
Conjugated Estrogens—Rash—Dactinomycin—ocular cancer	5.82e-05	0.00698	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Metabolism—PSPH—ocular cancer	5.76e-05	0.00223	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—GNA11—ocular cancer	5.65e-05	0.00218	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	5.52e-05	0.00213	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	5.49e-05	0.00212	CbGpPWpGaD
Conjugated Estrogens—Nausea—Dactinomycin—ocular cancer	5.49e-05	0.00658	CcSEcCtD
Conjugated Estrogens—COMT—Neuronal System—MDM2—ocular cancer	5.47e-05	0.00211	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—RB1—ocular cancer	5.44e-05	0.0021	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PSPH—ocular cancer	5.34e-05	0.00206	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	5.34e-05	0.00206	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	5.33e-05	0.00206	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	5.31e-05	0.00205	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MAML2—ocular cancer	5.25e-05	0.00203	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—GNAQ—ocular cancer	5.25e-05	0.00203	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	5.19e-05	0.002	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	5.07e-05	0.00196	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MAML2—ocular cancer	5.02e-05	0.00194	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—EIF1AX—ocular cancer	4.94e-05	0.00191	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—TP53—ocular cancer	4.93e-05	0.0019	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SAG—ocular cancer	4.8e-05	0.00185	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HDAC1—ocular cancer	4.73e-05	0.00183	CbGpPWpGaD
Conjugated Estrogens—ABCC3—NRF2 pathway—TGFB1—ocular cancer	4.72e-05	0.00182	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	4.65e-05	0.0018	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	4.64e-05	0.00179	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	4.63e-05	0.00179	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	4.63e-05	0.00179	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—MDM2—ocular cancer	4.62e-05	0.00178	CbGpPWpGaD
Conjugated Estrogens—ESR1—Leptin signaling pathway—HRAS—ocular cancer	4.46e-05	0.00172	CbGpPWpGaD
Conjugated Estrogens—ABCC4—NRF2 pathway—TGFB1—ocular cancer	4.43e-05	0.00171	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	4.38e-05	0.00169	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—GNA11—ocular cancer	4.31e-05	0.00167	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	4.27e-05	0.00165	CbGpPWpGaD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	4.27e-05	0.00165	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—AKT1—ocular cancer	4.26e-05	0.00165	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—E2F5—ocular cancer	4.25e-05	0.00164	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	4.22e-05	0.00163	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—CDKN1B—ocular cancer	4.21e-05	0.00163	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—E2F4—ocular cancer	4.16e-05	0.00161	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—E2F5—ocular cancer	4.11e-05	0.00159	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—RPL39—ocular cancer	4.08e-05	0.00158	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—RBL1—ocular cancer	4.08e-05	0.00158	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	4.07e-05	0.00157	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	4.07e-05	0.00157	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	4.04e-05	0.00156	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—E2F4—ocular cancer	4.03e-05	0.00156	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—GNAQ—ocular cancer	4.01e-05	0.00155	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—RPL39—ocular cancer	3.95e-05	0.00153	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—RBL1—ocular cancer	3.95e-05	0.00153	CbGpPWpGaD
Conjugated Estrogens—ESR1—Leptin signaling pathway—AKT1—ocular cancer	3.94e-05	0.00152	CbGpPWpGaD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—HRAS—ocular cancer	3.92e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	3.91e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—CDKN1A—ocular cancer	3.89e-05	0.0015	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	3.85e-05	0.00149	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—HDAC1—ocular cancer	3.84e-05	0.00148	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	3.82e-05	0.00148	CbGpPWpGaD
Conjugated Estrogens—ABCC2—NRF2 pathway—TGFB1—ocular cancer	3.74e-05	0.00145	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—EP300—ocular cancer	3.72e-05	0.00144	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	3.7e-05	0.00143	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	3.69e-05	0.00143	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	3.67e-05	0.00142	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—HDAC1—ocular cancer	3.67e-05	0.00142	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	3.54e-05	0.00137	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	3.54e-05	0.00137	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	3.51e-05	0.00136	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—CDKN2B—ocular cancer	3.44e-05	0.00133	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—RBBP4—ocular cancer	3.42e-05	0.00132	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	3.37e-05	0.0013	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—CDK2—ocular cancer	3.36e-05	0.0013	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	3.35e-05	0.00129	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—GNA11—ocular cancer	3.3e-05	0.00128	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—CDKN2B—ocular cancer	3.29e-05	0.00127	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TFDP1—ocular cancer	3.29e-05	0.00127	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—MYC—ocular cancer	3.24e-05	0.00125	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	3.24e-05	0.00125	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.23e-05	0.00125	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—TFDP1—ocular cancer	3.18e-05	0.00123	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	3.18e-05	0.00123	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	3.08e-05	0.00119	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—GNAQ—ocular cancer	3.07e-05	0.00119	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SAG—ocular cancer	3.02e-05	0.00117	CbGpPWpGaD
Conjugated Estrogens—COMT—Neuronal System—HRAS—ocular cancer	3e-05	0.00116	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	2.9e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PSPH—ocular cancer	2.89e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—TGFB1—ocular cancer	2.87e-05	0.00111	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	2.78e-05	0.00108	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	2.74e-05	0.00106	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GNA11—ocular cancer	2.7e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	2.69e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	2.68e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—E2F5—ocular cancer	2.67e-05	0.00103	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—TP53—ocular cancer	2.66e-05	0.00103	CbGpPWpGaD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—MYC—ocular cancer	2.65e-05	0.00102	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—E2F4—ocular cancer	2.62e-05	0.00101	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAML2—ocular cancer	2.61e-05	0.00101	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RBL1—ocular cancer	2.57e-05	0.000993	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—HRAS—ocular cancer	2.53e-05	0.000979	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MAML2—ocular cancer	2.53e-05	0.000978	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GNAQ—ocular cancer	2.51e-05	0.00097	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GNA11—ocular cancer	2.44e-05	0.000941	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	2.31e-05	0.000891	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PSPH—ocular cancer	2.3e-05	0.00089	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GNAQ—ocular cancer	2.26e-05	0.000875	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	2.25e-05	0.000869	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—AKT1—ocular cancer	2.24e-05	0.000864	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—E2F3—ocular cancer	2.23e-05	0.000861	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	2.21e-05	0.000855	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	2.21e-05	0.000853	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GNA11—ocular cancer	2.12e-05	0.00082	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TFDP1—ocular cancer	2.07e-05	0.0008	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	2.03e-05	0.000786	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.03e-05	0.000783	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GNAQ—ocular cancer	1.97e-05	0.000762	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HDAC1—ocular cancer	1.91e-05	0.000738	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GNA11—ocular cancer	1.91e-05	0.000738	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—EP300—ocular cancer	1.89e-05	0.000729	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.86e-05	0.00072	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	1.86e-05	0.000718	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—HDAC1—ocular cancer	1.85e-05	0.000715	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.83e-05	0.000706	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GNA11—ocular cancer	1.81e-05	0.000701	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PSPH—ocular cancer	1.78e-05	0.000687	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GNAQ—ocular cancer	1.77e-05	0.000686	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	1.77e-05	0.000685	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	1.71e-05	0.000663	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN2B—ocular cancer	1.71e-05	0.000662	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GNAQ—ocular cancer	1.69e-05	0.000652	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GNA11—ocular cancer	1.68e-05	0.000649	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—CDKN2B—ocular cancer	1.66e-05	0.000641	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAML2—ocular cancer	1.64e-05	0.000636	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TGFB1—ocular cancer	1.64e-05	0.000634	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	1.63e-05	0.00063	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.59e-05	0.000615	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GNAQ—ocular cancer	1.56e-05	0.000603	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—EP300—ocular cancer	1.44e-05	0.000557	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GNA11—ocular cancer	1.43e-05	0.000555	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.43e-05	0.000553	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.42e-05	0.000549	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.42e-05	0.000548	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.36e-05	0.000526	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—ocular cancer	1.35e-05	0.000522	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MYC—ocular cancer	1.33e-05	0.000516	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GNAQ—ocular cancer	1.33e-05	0.000516	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HRAS—ocular cancer	1.29e-05	0.000499	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MYC—ocular cancer	1.27e-05	0.000492	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HDAC1—ocular cancer	1.2e-05	0.000465	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.17e-05	0.000451	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—AKT1—ocular cancer	1.14e-05	0.000441	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—EP300—ocular cancer	1.1e-05	0.000427	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN2B—ocular cancer	1.08e-05	0.000417	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—E2F1—ocular cancer	9.89e-06	0.000382	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	9.86e-06	0.000381	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MDM2—ocular cancer	9.5e-06	0.000367	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNA11—ocular cancer	9.08e-06	0.000351	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—EP300—ocular cancer	9.02e-06	0.000349	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—ocular cancer	8.84e-06	0.000342	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—ocular cancer	8.7e-06	0.000336	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1B—ocular cancer	8.67e-06	0.000335	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNAQ—ocular cancer	8.44e-06	0.000326	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—EP300—ocular cancer	8.14e-06	0.000315	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—ocular cancer	8e-06	0.000309	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EP300—ocular cancer	7.61e-06	0.000294	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNA11—ocular cancer	7.25e-06	0.00028	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—EP300—ocular cancer	7.09e-06	0.000274	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNAQ—ocular cancer	6.74e-06	0.00026	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—ocular cancer	6.67e-06	0.000258	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—ocular cancer	6.63e-06	0.000256	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TGFB1—ocular cancer	6.62e-06	0.000256	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—ocular cancer	6.43e-06	0.000248	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—EP300—ocular cancer	6.38e-06	0.000246	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—EP300—ocular cancer	6.06e-06	0.000234	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MDM2—ocular cancer	5.98e-06	0.000231	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—EP300—ocular cancer	5.61e-06	0.000217	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNA11—ocular cancer	5.59e-06	0.000216	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1B—ocular cancer	5.46e-06	0.000211	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—ocular cancer	5.45e-06	0.000211	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.44e-06	0.00021	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—ocular cancer	5.21e-06	0.000201	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—ocular cancer	5.21e-06	0.000201	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNAQ—ocular cancer	5.2e-06	0.000201	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—ocular cancer	5.04e-06	0.000195	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—ocular cancer	4.92e-06	0.00019	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EP300—ocular cancer	4.79e-06	0.000185	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—ocular cancer	4.6e-06	0.000178	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—ocular cancer	4.46e-06	0.000172	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—ocular cancer	4.28e-06	0.000166	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—ocular cancer	4.18e-06	0.000161	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TGFB1—ocular cancer	4.17e-06	0.000161	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—ocular cancer	3.85e-06	0.000149	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—ocular cancer	3.66e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—ocular cancer	3.43e-06	0.000133	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—ocular cancer	3.39e-06	0.000131	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—ocular cancer	3.28e-06	0.000127	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—EP300—ocular cancer	3.03e-06	0.000117	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—ocular cancer	2.9e-06	0.000112	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—EP300—ocular cancer	2.42e-06	9.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—EP300—ocular cancer	1.87e-06	7.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—ocular cancer	1.83e-06	7.09e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—ocular cancer	1.46e-06	5.66e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—ocular cancer	1.13e-06	4.37e-05	CbGpPWpGaD
